Literature DB >> 29474266

Recovery from schizophrenia: is it possible?

Antonio Vita1,2, Stefano Barlati1.   

Abstract

PURPOSE OF REVIEW: Schizophrenia has a heterogeneous range of end states, from severe cases requiring repeated hospitalization to cases in which a single illness episode is followed by complete remission. The purpose of the present review is to examine recent literature on recovery in schizophrenia, focusing on the predictive factors and on the possibility to achieve it. RECENT
FINDINGS: Roughly half of schizophrenia patients recovered or significantly improved over the long term, suggesting that functional remission is possible. Several factors predict the course of schizophrenia, including demographic, clinical, and treatment characteristics, as well as socioeconomic variables. Antipsychotics are a fundamental element of schizophrenia treatment, although the available antipsychotics have significant limitations. In this context, psychosocial interventions are supported by substantial evidence of efficacy in many outcome measures and rehabilitation interventions should be considered as an evidence-based practice and need to become a part of the standard treatment of schizophrenia.
SUMMARY: As recovery is a multidimensional concept, some authors suggested that at least two areas should be taken into account: clinical remission and social functioning. Functional outcome should be a priority target for therapeutic interventions in schizophrenia and in this perspective measuring treatment response, remission and functional recovery is essential. Only an integrated and multifaceted approach involving pharmacotherapy, psychosocial interventions, and attention to environmental circumstances can improve outcome in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29474266     DOI: 10.1097/YCO.0000000000000407

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  24 in total

Review 1.  European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Stefano Barlati; Giulia Maria Giordano; Gabriele Nibbio; Merete Nordentoft; Til Wykes; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

2.  Low-Dose Ziprasidone in Combination with Sertraline for First-Episode Drug-Naïve Patients with Schizophrenia: a Randomized Controlled Trial.

Authors:  Cheng Zhu; Xiaoni Guan; Yuechan Wang; Jiahong Liu; Thomas R Kosten; Meihong Xiu; Fengchun Wu; Xiangyang Zhang
Journal:  Neurotherapeutics       Date:  2022-04-25       Impact factor: 6.088

3.  Recovery and Recovering in Older Adults with Schizophrenia: A 5-Tier Model.

Authors:  Carl I Cohen; Michael M Reinhardt
Journal:  Am J Geriatr Psychiatry       Date:  2020-04-02       Impact factor: 4.105

Review 4.  Schizophrenia outcomes in the 21st century: A systematic review.

Authors:  Peter Huxley; Anne Krayer; Rob Poole; Louise Prendergast; Sanjaya Aryal; Richard Warner
Journal:  Brain Behav       Date:  2021-05-15       Impact factor: 2.708

5.  The Puzzle of Functional Recovery in Schizophrenia-Spectrum Disorders-Replicating a Network Analysis Study.

Authors:  Bernardo Melo Moura; Adela-Maria Isvoranu; Veronika Kovacs; Geeske Van Rooijen; Therese Van Amelsvoort; Claudia J P Simons; Agna A Bartels-Velthuis; P Roberto Bakker; Machteld Marcelis; Lieuwe De Haan; Frederike Schirmbeck
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

6.  Evidence-Based Integrated Intervention in Patients with Schizophrenia: A Pilot Study of Feasibility and Effectiveness in a Real-World Rehabilitation Setting.

Authors:  Gabriele Nibbio; Stefano Barlati; Paolo Cacciani; Paola Corsini; Alessandra Mosca; Anna Ceraso; Giacomo Deste; Antonio Vita
Journal:  Int J Environ Res Public Health       Date:  2020-05-12       Impact factor: 3.390

Review 7.  Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety.

Authors:  István Laszlovszky; Ágota Barabássy; György Németh
Journal:  Adv Ther       Date:  2021-06-06       Impact factor: 3.845

8.  From Wish to Reality: Soteria in Regular Care-Proof of Effectiveness of the Implementation of Soteria Elements in Acute Psychiatry.

Authors:  Theresa Wolf; Philine Fabel; Adrian Kraschewski; Maria C Jockers-Scherübl
Journal:  Front Psychiatry       Date:  2021-07-09       Impact factor: 4.157

9.  Demographic and clinical profile of patients utilising a transitional care intervention in the Western Cape, South Africa.

Authors:  Henmar F Botha; Liezl Koen; Daniel J H Niehaus; Yanga Vava; Karis Moxley; Ulla Botha
Journal:  S Afr J Psychiatr       Date:  2020-08-26       Impact factor: 1.550

Review 10.  Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review.

Authors:  Stefano Barlati; Giacomo Deste; Alessandro Galluzzo; Anna Paola Perin; Paolo Valsecchi; Cesare Turrina; Antonio Vita
Journal:  Front Pharmacol       Date:  2019-01-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.